AstraZeneca PLC (AZN)
203.34
+2.61
(+1.30%)
USD |
NYSE |
Apr 02, 16:00
203.34
0.00 (0.00%)
After-Hours: 18:05
AstraZeneca Research and Development Expense (TTM) : 13.84B for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| GSK Plc | 9.632B |
| Mereo BioPharma Group Plc | 17.81M |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Biodexa Pharmaceuticals Plc | 5.234M |
| BioNTech SE | 2.379B |